- Home
- AVIR vs CCIX Comparison
AVIR vs CCIX Comparison
Compare AVIR & CCIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$5.94
Company Overview
Basic Information| Metric | AVIR | CCIX |
|---|---|---|
| Founded | 2012 | 2023 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 450.9M | 390.8M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | AVIR | CCIX |
|---|---|---|
| Price | $5.94 | $10.72 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 475.6K | 14.7K |
| Earning Date | 05-11-2026 | 11-07-2013 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $351,367,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $45.59 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.46 | $10.46 |
| 52 Week High | $6.45 | $11.66 |
Technical Indicators
Market Signals| Indicator | AVIR | CCIX |
|---|---|---|
| Relative Strength Index (RSI) | 62.91 | 60.61 |
| Support Level | $3.33 | $10.55 |
| Resistance Level | $6.45 | $10.71 |
| Average True Range (ATR) | 0.29 | 0.02 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 73.63 | 75.00 |
Price Performance
Historical Comparison AVIR
CCIX
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.
About CCIX Churchill Capital Corp IX Ordinary Shares
Churchill Capital Corp IX is a blank check company.